Biopharma
Inactivated vaccine in oily adjuvant for the prevention of Low Pathogenic Avian Influenza (LPAI)
sub type H9N2 – Moroccan strains:… at least 109 DIO/ml before inactivation allowing obtaining
of a titer inhibiting hemagglutination by at least 5 log2.
Pharmaceutical form:
Oily suspension for injection.
Indications:
Active immunization of chicken and turkey species against
Low Pathogenic Avian Influenza-LPAI subtype
H9N2, primary vaccination or booster vaccination
Administration:
Intramuscular route at the keel bone, subcutaneous route
at the lower part of the neck.